Abstract
Depleting components of the cBAF chromatin remodeling complex improves antitumor T-cell function.
Major Finding: Depleting components of the cBAF chromatin remodeling complex improves antitumor T-cell function.
Concept: Chromatin remodeling complexes cBAF and INO80 enforce the epigenetic state of exhausted CD8+ T cells.
Impact: Targeting ARID1A can enhance CD8+ T-cell persistence and viability, improving immunotherapy outcomes.
Chronic T-cell stimulation promotes T-cell exhaustion and reduced immunotherapy efficacy as well as global changes to the transcriptome and epigenome; however, the factors that drive this transformation remain undetermined. By performing a genome-wide CRISPR screen in an in vitro model of T-cell exhaustion that recapitulates in vivo transformations, Belk and colleagues identified the chromatin remodeling complexes cBAF and INO80 as critical genetic regulators of T-cell exhaustion. An in vivo CRISPR screen (limited to the top 300 hits of the in vitro genome-wide screen) in two murine models also showed consistent results with perturbations of cBAF and INO80 chromatin remodelers preventing T-cell exhaustion in response to chronic antigen stimulation. Functional assays revealed that blocking T-cell exhaustion by depleting subunits of the cBAF complex improves T-cell antitumor activity in vivo, and genetic ablation of the cBAF component ARID1A in primary human CD8+ T cells increases viability, persistence, and antitumor activity. In order to understand the molecular mechanism driving improved T-cell function, a limited single-guide RNA pool targeting INO80 and BAF complex components was generated and showed, using Perturb-seq on in vivo murine T-cell populations, that cBAF and INO80 complexes were found to have distinct transcriptional roles in T-cell exhaustion. Targeting cBAF subunits Arid1a, Smarcd2, and Smarcc1 induced shared gene expression changes, including an increase in effector molecules Gzmb and Ifng and a global enrichment in T-cell activation programs, while targeting INO80 complex members significantly altered metabolism-related genes. Assay for transposase-accessible chromatin with high-throughput sequencing following ARID1A knockout in both murine and primary human CD8+ T cells further exhibited a global decrease in accessibility of genomic regions unique to chronic stimulation, with the epigenome of these ARID1A knockout cells being more similar to naïve and activated T-cell populations. In summary, this study demonstrates that cBAF and INO80 complexes epigenetically dictate T-cell exhaustion in response to chronic stimulation and suggests improvement can be made to cancer immunotherapies through modulation of this epigenetic state.
Note:Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.